Navigation Links
Thomson Reuters Speeds Regulatory Decision Making with New Pharmaceutical Intelligence Solution
Date:6/25/2012

PHILADELPHIA, June 25, 2012 /PRNewswire/ -- The Intellectual Property & Science division of Thomson Reuters unveiled Cortellis for Regulatory Intelligence at the DIA 2012 Annual Meeting in Philadelphia today. This new offering is the next generation of Thomson Reuters IDRAC™, the company's best-in-class regulatory intelligence tool that provides pharmaceutical professionals with reliable and accurate global regulatory information to gain competitive advantage and minimize regulatory risks.

Cortellis for Regulatory Intelligence is a comprehensive regulatory solution  that  helps regulatory affairs professionals make timely and more informed decisions by providing them with exclusive regulatory information for multi-country filings, comparing existing and emerging competitive products, preparing for committee meetings and inspections, and keeping up-to-date on regulatory changes as they happen.

"Our business depends on understanding the global regulatory landscape and the continually evolving submission approval requirements," said Rick Riegel, CEO of Liquent. "By using Cortellis for Regulatory Intelligence, we can assure our clients that our knowledge is supplemented by the industry's leading regulatory intelligence database.  In addition, it provides the opportunity to explore new ways of incorporating that knowledge into our own solutions via the available API's in the Cortellis platform."

This new regulatory intelligence solution enables companies to more quickly and easily leverage the comprehensive and enhanced regulatory content via Thomson Reuters Cortellis™, the premiere Life Sciences platform.

Cortellis delivers impressive search speeds and more relevant results due to an all-new search engine in a highly intuitive user interface. The search engine allows for rapid free-text searching, making it possible for users to search across the platform's entire regulatory database without the need to design complex search strategies, while custom filters are available to increase accuracy. Cortellis will also make valuable information more accessible and is compatible with mobile devices, including smartphones and tablet devices, providing a more interactive user experience, and the freedom to stay informed while on the go.

Here is what some pharmaceutical professionals have said after using Cortellis for Regulatory Intelligence:

  • "Cortellis for Regulatory Intelligence is 'remarkably' different in a good way."
  • "This search platform is so different compared to standard IDRAC, it's almost incomparable! I think I will use it in a completely different way. Very nice!"
  • "We have explored Cortellis for Regulatory Intelligence and we are very pleased with the easy sorting capabilities."

"We are very excited to announce the launch of Cortellis for Regulatory Intelligence and think it has the power to transform the way the industry approaches and utilizes pharmaceutical regulatory intelligence," said Jon Brett-Harris, executive vice president of Life Sciences at Thomson Reuters. "The industry's needs for accessing regulatory intelligence are changing and Thomson Reuters is responding to the new demands. Cortellis for Regulatory Intelligence not only allows our customers to make stronger, better informed decisions, but will greatly improve their ability to be compliant."

To learn more about Cortellis for Regulatory Intelligence, visit cortellis.thomsonreuters.com or stop by our booth, #3001, at the DIA Annual Meeting between June 24 - 28.

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
2. Thomson Reuters Finds Increase in New Research for Neglected Tropical Diseases
3. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
4. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
5. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
6. Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers
7. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
8. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
9. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
10. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... 24, 2017 SW Safety Solutions, Inc., the ... announces the release of the latest advancement in workplace ... example of leading edge nitrile glove technology features SW,s ... more tactile grip on wet and oily surfaces and ... TracTek and a suite of other advanced SW technologies, ...
(Date:4/20/2017)... 20, 2017  Vivify Health, the pioneer and market ... awarded a very significant patent for the advancement of ... care via digital health.  This landmark patent provides the ... further secures Vivify,s position as the leader in remote ... the first company to apply consumer mobile devices, wireless ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
Breaking Medicine Technology:
(Date:4/26/2017)... ST. LOUIS (PRWEB) , ... April 26, 2017 ... ... is designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping ... an economic alternative to dairy proteins, providing direct cost savings as well as ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... support, and collaboration, announces Mirroring360 Pro . This new addition to the ... collaboration experience for education and business. , Mirroring360 Pro enables educators, business professionals ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... decision-makers are preparing for how his administration could impact the employee benefits industry. ... what changes are most likely to make it through Congress. His discussion will ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... modern procedure that achieves results in a fraction of the time as traditional ... NV, with Significance Dental Specialists, now offers this revolutionary treatment with or without ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
Breaking Medicine News(10 mins):